secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0001171843-23-005696
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Joint Corp. Q2 prelim: rev $29.3M (+18%), Adj EBITDA $3.2M (+23%), cuts FY guidance
--------------------------------------------------------------------------------

- Revenue $29.3M (+18% YoY); operating loss improved to $0.375M from $1.3M loss in Q2 2022.
- Adjusted EBITDA $3.2M (+23% YoY); system-wide sales $120.1M (+13%); comp sales +5%.
- FY 2023 revenue guidance cut to $115-118M from $123-128M; Adj EBITDA cut to $11-12.5M from $12.5-14M.
- Plans to cull ~10% of corporate clinic portfolio via accretive transactions to improve profitability.
- Cash $13.6M; opened 26 new clinics in Q2; total clinics 890 at quarter end, 911 as of Sept 12.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000117184323005696/0001171843-23-005696-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000117184323005696/f8k_091323.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-005696

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer